N52.37
Erectile dysfunction following prostate ablative therapy
Clinical Classification Guidelines
Inclusion Terms
- Erectile dysfunction following cryotherapy
- Erectile dysfunction following other prostate ablative therapies
- Erectile dysfunction following ultrasound ablative therapies
Medical Intelligence & Overview
Erectile dysfunction (ED) is a common concern for men who have undergone prostate ablative therapies, including cryotherapy, ultrasound, or other targeted treatments. This condition refers to the difficulty in achieving or maintaining an erection sufficient for satisfactory sexual activity. The ICD-10 code N52.37 specifically relates to ED that develops after prostate ablative procedures, which are often performed to treat prostate cancer or benign prostatic hyperplasia. While these treatments can be effective for managing prostate issues, they may also impact nerves and blood vessels involved in erectile function, leading to subsequent erectile difficulties.
Causes & Symptoms
Clinical Causes: Nerve damage caused by the ablative procedure Blood vessel injury or scarring in the pelvic region Altered blood flow due to tissue changes post-treatment Psychological factors related to cancer diagnosis or treatment side effects Hormonal changes resulting from prostate treatment
Key Symptoms: Difficulty achieving an erection even with sexual arousal Reduced erectile rigidity or firmness Decreased sexual satisfaction Loss of spontaneous erections Concerns about ongoing sexual performance
Diagnostic & Treatment
Diagnosis Path: Diagnosis of ED following prostate ablative therapy involves a detailed medical history review, physical examination, and possibly laboratory tests. Healthcare providers may inquire about the timing of erectile issues relative to treatment, associated symptoms, and psychological factors. Additional assessments such as nocturnal penile tumescence testing or blood flow studies can help determine the underlying cause. An open discussion about sexual function is essential to guide appropriate management.
Treatment Protocols: Management strategies for ED post-therapy aim to improve erectile function and address individual patient needs. Common options include: - Oral medications such as phosphodiesterase inhibitors (e.g., sildenafil, tadalafil) - Vacuum erection devices that enhance blood flow - Penile injections or suppositories that induce erections - Penile implants for more severe cases - Psychological counseling to address emotional or relational concerns - Lifestyle modifications, including exercise, smoking cessation, and healthy diet, to promote vascular health It is important to consult with a healthcare provider to determine the most suitable treatment plan based on individual condition and preferences.
Clinical Advice & FAQs
Billing Guidance
Is N52.37 a billable ICD-10 code?
Yes, N52.37 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N52.37?
Clinical documentation must specify the nature of Erectile dysfunction following prostate ablative therapy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference